Skeletal muscle insulin resistance after trauma: insulin signaling and glucose transport

Lisa Strömmer1, Johan Permert1, Urban Arnelo1, Camilla Koehler1, Bengt Isaksson1, Jörgen Larsson1, Inger Lundkvist1, Marie Björnholm2, Yuichi Kawano2, Harriet Wallberg-Henriksson2, and Juleen R. Zierath2

1 Arvid Wretlinds Laboratory for Metabolic and Nutritional Research, Department of Surgery, Karolinska Institute at Huddinge University Hospital, 141 86 Huddinge; and 2 Department of Clinical Physiology, Karolinska Institute at Karolinska Hospital, 171 77 Stockholm, Sweden

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

Surgical trauma induces peripheral insulin resistance; however, the cellular mechanism has not been fully elucidated. We examined the effects of surgical trauma on insulin receptor signaling and glucose transport in skeletal muscle, a tissue that plays a predominant role in maintaining glucose homeostasis. Surgical trauma was induced by intestinal resection in the rat. Receptor phosphorylation was not altered with surgical trauma. Phosphotyrosine-associated phosphatidylinositol (PI) 3-kinase association was increased by 60 and 82% compared with fasted and fed controls, respectively (P < 0.05). Similar results were observed for insulin receptor substrate-1-associated PI 3-kinase activity. Insulin-stimulated protein kinase B (Akt kinase) phosphorylation was increased by 2.2-fold after surgical trauma (P < 0.05). The hyperphosphorylation of Akt is likely to reflect amplification of PI 3-kinase after insulin stimulation. Submaximal rates of insulin-stimulated 3-O-methylglucose transport were reduced in trauma vs. fasted rats by 51 and 38% for 100 and 200 µU/ml of insulin, respectively (P < 0.05). In conclusion, insulin resistance in skeletal muscle after surgical trauma is associated with reduced glucose transport but not with impaired insulin signaling to PI 3-kinase or its downstream target, Akt. The surgical trauma model presented in this report provides a useful tool to further elucidate the molecular mechanism(s) underlying the development of insulin resistance after surgical trauma.

insulin receptor; phosphatidylinositol 3-kinase; Akt/protein kinase B; surgical stress

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

TRAUMA-INDUCED METABOLIC STRESS from surgery or injury is associated with alterations in carbohydrate metabolism (13, 20), including increased glucose production (6) and decreased peripheral glucose utilization (5, 41). The most common form of posttraumatic insulin resistance is iatrogenic in nature, developing in the postoperative state. Several lines of evidence suggest that peripheral tissues are the major site of the trauma-induced insulin resistance (3, 31). Glucose clamp studies in postoperative patients revealed that impaired glucose disposal develops in peripheral tissues (3, 17, 41). Interestingly, the magnitude of surgically induced insulin resistance is related to the degree of surgical trauma, and this persists for 2-3 wk after uncomplicated abdominal surgery (32, 40-42). Despite the considerable progress in understanding the development of trauma-induced insulin resistance at the whole body level, the cellular mechanism remains unclear.

Peripheral insulin resistance after posttraumatic stress may occur in response to defects in early or intermediate components of the insulin signal transduction pathway and/or in response to defects at the level of glucose transport, a rate-limiting step in glucose utilization (10). One of the earliest postreceptor events leading to the metabolic effects of insulin includes the phosphorylation of the insulin receptor substrate-1 (IRS-1) on tyrosine residues (46). IRS-1 serves as a multiple docking site for proteins containing Src-homology 2 domains, such as phosphatidylinositol (PI) 3-kinase (46). Multiple lines of evidence suggest that PI 3-kinase plays a central role in mediating insulin signaling to glucose transport (8, 37). Recently, we have reported that reduced insulin-stimulated PI 3-kinase activity is coupled to reduced glucose transport in skeletal muscle from patients with non-insulin-dependent diabetes mellitus (2). Thus defects at the level of the insulin signal transduction pathway may contribute to impaired glucose transport (2, 14, 18, 19) and glucose transporter isoform GLUT-4 translocation (49), and this may result in reduced whole body glucose homeostasis. In adipocytes, insulin resistance after trauma appears to develop from a postreceptor lesion, since glucose uptake is decreased despite normal insulin binding to the insulin receptor (34). Whether the reduced glucose transport with surgical trauma is a primary defect due to altered GLUT-4 traffic from an intracellular pool to the plasma membrane or a secondary defect due to alterations in the insulin signal transduction cascade remains unknown.

In the present study, we have adopted a small intestinal bowel resection model in fasted rats to delineate the underlying mechanism for the apparent peripheral insulin resistance that arises from surgical trauma. We have assessed early, intermediate, and final components of the insulin signal transduction pathway to glucose transport in skeletal muscle. Specifically, we have assessed insulin receptor binding and autophosphorylation, PI 3-kinase activity and association to phosphotyrosines, protein kinase B (Akt kinase) phosphorylation, and glucose transport to determine whether defects in insulin signaling contribute to impaired glucose homeostasis after postoperative stress.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Animals. Male Wistar rats (320-350 g; B&K Universal, Stockholm, Sweden) were housed under controlled conditions with a 12:12-h light-dark cycle (lights-on 7 AM to 7 PM). Rats were provided standard laboratory chow and water ad libitum for 1 wk before experimentation. Rats were divided into three groups: fed (n = 25), fasted controls (n = 22), and trauma (n = 30). Food was withdrawn 16 h before experimentation from rats in the fasted and trauma groups and immediately before experimentation from rats in the fed group.

Operative procedure. All procedures were conducted with approval from the local ethical committee. Rats were anesthetized by an intraperitoneal injection of ketamine and xylazine (70 and 10 mg/kg, respectively). Blood samples were obtained for preoperative determination of glucose levels from the tail vein. An 8-cm incision was made along the abdomen. Five centimeters distal to the Treitz's ligament, a 5-cm small bowel resection was performed. Thereafter, the bowel was sutured with absorbable sutures (6/0, Vicryl), and the abdominal cavity was closed using eight sutures (4/0, Vicryl). The animals were returned to individual cages and had free access to water. Two hours later, rats were reanesthetized, and a plastic catheter (Venflon, 0.8/25 mm) was inserted into the internal jugular vein. Blood samples were obtained for determination of glucose and insulin levels. Thereafter, a bolus injection of 1 ml of 0.9% NaCl was administered under 1 min (iv), and a muscle biopsy was obtained from the right gastrocnemius muscle. Insulin was injected intravenously (10 U/kg, in 1 ml of 0.9% NaCl and 0.01% BSA) as a bolus delivered under 1 min. Four minutes after the injection, a second biopsy was obtained from the left gastrocnemius muscle. The muscle specimens were immediately frozen on excision and stored in liquid nitrogen until analysis.

Blood chemistry. In a subgroup of rats, a catheter was inserted into the jugular vein immediately after the second anesthesia, and blood samples were collected for determination of blood glucose and plasma levels of insulin, nonesterified free fatty acids (NEFAs), epinephrine, cortisol, and lactate. Blood glucose and plasma lactate were determined enzymatically (YSI 2000 system; Kebo, Stockholm, Sweden). Plasma insulin was analyzed using a commercially available kit (Diagnostica, Falkenberg, Sweden). Plasma NEFAs were analyzed using a kit from Wako Chemicals (Neuss, Germany). Plasma epinephrine was determined by HPLC with electrochemical detection, with 3,4-dihydroxybenzylamine hydrochloride as an internal standard (16). The size of the chromatography column was 150 × 4.6 mm (Catecholamine column 5 SA; Machery-Nagel, Düren, Germany), and an EC 2000 electrochemical detector was utilized (Therm Separation Products, Riviera Beach, FL). Serum cortisol was measured in a solid-phase time-resolved fluoroimmunoassay (9), based on a competitive reaction between europium-labeled cortisol and sample cortisol (Wallac Oy, Turku, Finland).

Insulin receptor binding and phosphorylation. Gastrocnemius muscle biopsies were ground to a fine powder with a mortar and a pestle in liquid nitrogen and immediately homogenized in ice-cold buffer as previously described (15). Homogenates were solubilized by gentle mixing for 30 min at 4°C. After centrifugation (35,000 g for 45 min at 4°C), the supernatant was removed, protein was determined (BCA protein assay kit, Pierce, Rockford, IL), and aliquots were stored at -70°C. Insulin receptor binding and phosphorylation were determined as described previously (15). A portion of the supernatant was immunoprecipitated overnight at 4°C with a monoclonal antibody directed against the beta -subunit of the insulin receptor (IR 29B4, Santa Cruz Biotechnology, Santa Cruz, CA). The precipitate was further incubated for 30 min at 4°C with a secondary monoclonal antibody (anti-IgG1; DAKO, Copenhagen, Denmark), followed by incubation for 1 h at 4°C with 125 µl of protein A (Pansorbin cells). The immunoprecipitates were divided into four equal aliquots, washed, and resuspended in Tris buffer containing 1% Triton X-100 and 1 mM phenylmethylsulfonyl fluoride. A second aliquot of the supernatant (4 mg of protein) was used to immunoprecipitate tyrosine-phosphorylated proteins (overnight at 4°C) with the use of an anti-phosphotyrosine antibody (PY20; Signal Transduction Laboratories, Lexington, KY). The immunocomplex was incubated with secondary antibody (anti-IgG2b, DAKO) and protein G. The complex was washed three times and resuspended in buffer (50 mM Tris, 1% Triton X-100, 1 mM Pervanadate) and divided into four aliquots. In three aliquots of the insulin receptor immunoprecipitate, insulin receptors were assessed using 125I-labeled insulin [25,000 counts/min (cpm)] overnight. Nonspecific binding was determined in one of the aliquots by addition of unlabeled insulin (60 µM). To detect insulin receptor tyrosine phosphorylation, the anti-phosphotyrosine immunoprecipitates were incubated with 125I-insulin (25,000 cpm) overnight. The pellets were washed three times, and binding of labeled insulin in anti-insulin receptor (alpha -IR) and anti-phosphotyrosine (alpha -PY) immunoprecipitates was determined in a gamma counter. Bound-free quotients per milligram protein were calculated for the two different immunoprecipitated samples. Quotients of immunoprecipitates were used to calculate fraction of phosphorylated receptors, corrected for receptor binding under basal and insulin-stimulated conditions.

Tyrosine phosphorylation of IRS-1. Equal amounts of protein (2 mg) were immunoprecipitated overnight with IRS-1 antibody (gift from Dr. Morris White, Joslin Diabetes Center, Boston, MA) coupled to protein A-Sepharose. The immunoprecipitates were washed as described (14), resuspended in Laemmli sample buffer with 100 mM dithiothreitol, and heated (95°C) for 6 min. The proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and blocked in Tris-buffered saline (TBS)-T (10 mM Tris, 0.01% Tween, pH 7.8) containing 3% milk. The membranes were immunoblotted with horseradish peroxidase-conjugated anti-phosphotyrosine antibody (RC-20; Signal Transduction) and washed thereafter with TBS-T. IRS-1 was visualized by enhanced chemiluminescence (Amersham, Arlington Heights, IL) and quantified by densitometric scanning (Imagemaster, Pharmacia Biotech, Uppsala, Sweden).

Phosphotyrosine and IRS-1 association with the 85-kDa subunit of PI 3-kinase. Phosphotyrosine- and IRS-1-associated PI 3-kinase was determined by Western blot analysis. Equal amounts of protein (1.5 mg) were immunoprecipitated with anti-phosphotyrosine or anti-IRS-1 antibody as described in Insulin receptor binding and phosphorylation. The immune complexes were washed and solubilized in Laemmli sample buffer. Proteins were separated by SDS-PAGE, transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore, Bedford, MA), and blocked as described above for tyrosine phosphorylation of IRS-1. The membranes were incubated with a polyclonal anti-PI 3-kinase antibody (1:500; Upstate Biotechnology, Lake Placid, NY) in TBS-T containing 5% milk. The membranes were subsequently washed and incubated with a horseradish peroxidase-labeled anti-rabbit antibody (1:5,000) in TBS-T containing 5% milk. After additional washing, the bound antibodies were detected by enhanced chemiluminescence, and PI 3-kinase was quantitated by densitometric scanning.

Phosphotyrosine- and IRS-1-associated PI 3-kinase activity. Equal amounts of protein (2 mg) were immunoprecipitated overnight (4°C) with anti-phosphotyrosine or anti-IRS-1 antibody coupled to protein A-Sepharose. The immune complexes were washed as described above and resuspended in 40 µl of buffer (20 mM HEPES, pH 7.5, 180 mM NaCl). PI 3-kinase activity was assessed directly on the protein A-Sepharose beads as previously reported (19, 49). The bands corresponding to PI 3-phosphate were quantitated using a phosphorimager (Fujix 2000, Fuji Photo Film, Fuji, Japan).

Akt phosphorylation. Aliquots of muscle homogenate (40 µg) were solubilized in Laemmli sample buffer with 100 mM dithiothreitol and heated (95°C) for 6 min. Proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted as described in Tyrosine phosphorylation of IRS-1 with the use of a phosphospecific antibody that recognizes Akt when phosphorylated at Ser 473 (New England Biolabs, Beverly, MA). Phosphorylated Akt was visualized by enhanced chemiluminescence and quantified by densitometric scanning.

Glucose transport. Media were prepared from oxygenated (95% O2-5% CO2) Krebs-Henseleit buffer (KHB) containing 5 mM HEPES and 0.1% BSA (RIA grade). Immediately after the second anesthesia, isolated soleus muscles were removed from a subgroup of rats. The muscle was divided into three equal portions, and the two outer portions (20 mg each) were used to assess glucose transport (45). The muscle specimens were initially incubated (30°C) for 15 min in KHB containing 2 mM pyruvate and 18 mM mannitol. Thereafter, muscles were incubated in the presence of insulin (0, 100, 200, and 1,000 µU/ml) for 10 min in KHB containing 20 mM mannitol. Glucose transport was assessed under basal or insulin-stimulated conditions using 8 mM 3-O-[methyl-3H]glucose (2.5 µCi/mmol) and 12 mM [14C]mannitol (26.3 µU/mmol). The muscles were processed as described (45). Glucose transport activity is expressed as micromoles of glucose analog accumulated per milliliter of intracellular water per hour.

Chemicals. Human insulin (Actrapid) was purchased from Novo Nordisk (Bagsværd, Denmark). Protein G-Sepharose-4 fast flow was from Pharmacia (Uppsala, Sweden), and protein A (Pansorbin cells) was from Calbiochem-Novabiochem (La Jolla, CA). All reagents for SDS-PAGE were from Novex (San Diego, CA), and reagents for the protein assay were from Pierce. 125I-insulin was from Amersham (Buckinghamshire, UK). All other radioisotopes were purchased from ICN Biomedical (Costa Mesa, CA). Phosphatidylinositol was from Avanti-Polar Lipids (Alabaster, AL). Aluminum-backed silica gel-60 thin-layer chromatographic plates were from Merck (Darmstadt, Germany). Other standard chemicals and reagents, including BSA, were purchased from Sigma (St. Louis, MO).

Statistical analysis. Data are presented as means ± SE. Statistical analysis was performed using the Student's unpaired t-test for pre- and postglucose values and for Akt phosphorylation. Comparisons between the groups were performed with ANOVA two-way multivariance analysis followed by the Bonferroni correction (PI 3-kinase) or Dannet one-tailed post hoc test (glucose transport). P < 0.05 was considered statistically significant.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Blood glucose and plasma insulin levels. Basal glucose was significantly lower in fasted control and traumatized rats compared with fed control rats (4.5 ± 0.3 and 4.3 ± 0.2 vs. 7.0 ± 0.4 mM, respectively; Table 1). After insertion of a catheter in the jugular vein, bloodglucose was significantly increased in fed rats (7.0 ± 0.4 vs. 12.0 ± 0.5 mM), whereas no change was observed in fasted controls (4.5 ± 0.3 vs. 5.3 ± 0.4 mM). In traumatized rats, glucose levels were significantly elevated compared with fasted controls (4.3 ± 0.3 vs. 6.5 ± 0.4 mM, P < 0.05). Plasma insulin was significantly higher in fed rats compared with traumatized and fasted control rats (398 ± 94 vs. 56 ± 11 and 68 ± 7 pM, respectively; P < 0.01). The insulin values in fasted and traumatized rats were similar.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Plasma and serum concentrations of hormones and metabolites

Plasma epinephrine and cortisol levels. In fed and fasted controls, plasma epinephrine concentrations were <0.3 nM, whereas in traumatized rats, all values were >0.3 nM (range 0.88-4.07 nM) (Table 1). Statistical analysis was not performed because of the wide variation in the data. Serum cortisol values in traumatized rats were time matched to fasted and fed control rats to correct for diurnal variation. Serum cortisol levels were similar among all animals (310 ± 29, 271 ± 43, and 331 ± 64 mM in fed, fasted control, and traumatized rats, respectively). In fasted control and trauma groups, serum cortisol levels varied from 76 to 446 mM and from 87 to 497 mM, respectively.

Plasma NEFAs and lactate levels. Plasma NEFA was significantly higher in fed rats compared with fasted control and traumatized rats (1.9 ± 0.3 vs. 0.7 ± 0.2 and 0.3 ± 0.1 mM, respectively; P < 0.01; Table 1). Plasma NEFA levels in traumatized rats tended to be lower than in fasted control rats (P < 0.08). Plasma lactate concentration was comparable among all groups (1.1 ± 0.2, 0.9 ± 0.1, and 0.8 ± 0.1 mM for fed, fasted controls, and traumatized rats, respectively).

Insulin receptor binding and autophosphorylation. The bolus injection of insulin (10 U/kg) resulted in high circulating levels of insulin concentrations (>3,500 pM), which were maintained throughout the muscle biopsy procedure (data not shown) and resulted in a marked increase in insulin receptor phosphorylation (Table 2). The increase in insulin receptor phosphorylation in response to insulin was approximately twofold greater in fasted and traumatized rats compared with fed rats. In fasted and traumatized rats, insulin receptor binding was not altered after insulin stimulation. However, in fed rats, insulin receptor binding decreased significantly (P < 0.05) with insulin stimulation (Table 2). Anti-insulin receptor immunoblots of insulin receptor precipitates failed to reveal any reduction in insulin receptor content before and after insulin stimulation (data not shown). Thus the decrease in insulin receptor binding in fed control rats was not due to an actual reduction in the number of receptors in the insulin-stimulated state. The ratio of the bound-free quotients of 125I-insulin bound in immunoprecipitates was determined before (-alpha -PY/-alpha -IR) and after insulin stimulation (+alpha -PY/+alpha -IR) as shown in Table 2. When insulin receptor phosphorylation was corrected for the insulin binding capacity under basal and insulin-stimulated conditions, this fraction was increased to the same extent in all rats. The insulin-stimulated increase in phosphorylation was greater in fasted (P < 0.05) and traumatized rats (P < 0.05) compared with fed controls (Table 2).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Insulin receptor autophosphorylation and binding in phosphotyrosine and insulin receptor immunoprecipitates per mg protein

IRS-1 tyrosine phosphorylation. We assessed the effects of surgical trauma on basal and in vivo insulin-stimulated tyrosine phosphorylation of IRS-1 in skeletal muscle (Fig. 1). Insulin-stimulated tyrosine phosphorylation of IRS-1, expressed as percentage of the insulin effect for control rats, was not altered by surgical trauma (100 ± 9 vs. 104 ± 20% for n = 8 control vs. n = 8 traumatized rats, respectively).


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 1.   Representative immunoblot of basal and insulin-stimulated tyrosine phosphorylation of insulin receptor substrate (IRS)-1 in skeletal muscle from fed (n = 8) or fasted (n = 8) traumatized rats. Hindlimb muscle biopsies were homogenized, and equal amounts of solubilized protein (2 mg) were immunoprecipitated with anti-IRS-1. Tyrosine phosphorylation of IRS-1 was assessed under basal (B) or insulin-stimulated (I) conditions as described in METHODS by immunoblotting with anti-phosphotyrosine antibody. Nos. at left are molecular mass.

Phosphotyrosine- and IRS-1-associated PI 3-kinase. An insulin-induced appearance of the p85 subunit of PI 3-kinase was assessed by Western blot analysis of phosphotyrosine or IRS-1 immunoprecipitates. The presence of PI 3-kinase was confirmed with a positive control and PI 3-kinase immunoblots with the use of an antibody to recognize an 85-kDa form of PI 3-kinase. An internal standard was included on all blots to correct for interassay variability. In the basal state, PI 3-kinase association to tyrosine-phosphorylated proteins was similar among the three groups (Fig. 2). However, under insulin-stimulated conditions, PI 3-kinase association to tyrosine-phosphorylated proteins was increased 175 ± 10, 200 ± 19, and 320 ± 38% for fed control, fasted control, and traumatized rats, respectively. In traumatized rats, there was a significant increase in PI 3-kinase association compared with fasted (P < 0.05) and fed (P < 0.005) rats. Similar results were observed in IRS-1 immunoprecipitates; surgical trauma led to a 60% increase in insulin-stimulated PI 3-kinase association to IRS-1 (226 ± 26 vs. 362 ± 36% for fed control vs. traumatized rats, respectively; P < 0.05).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Basal and insulin-stimulated phosphotyrosine-associated phosphatidylinositol (PI) 3-kinase content in fed (n = 10), fasted (n = 8), and traumatized (n = 8) rats. Hindlimb muscle biopsies were homogenized, and equal amounts of solubilized proteins were immunoprecipitated with anti-phosphotyrosine (alpha -PY) as described in METHODS. Samples were resolved by SDS-PAGE and immunoblotted with alpha -PI 3-kinase. Results are expressed as the mean ± SE percent increases over fed control rats. * P < 0.05 and dagger  P < 0.005 vs. control fed rats.

Phosphotyrosine- and IRS-1-associated PI 3-kinase activity. Recent studies provide evidence for several PI 3-kinase adapter subunit variants, which exhibit different insulin-induced PI 3-kinase elevating responses (1, 21, 22, 38). Thus the increase in p85 bound to tyrosine-phosphorylated proteins or to IRS-1 noted in muscle from surgically traumatized rats may not translate to increased activity of PI 3-kinase. Consequently, we assessed phosphotyrosine- or IRS-1-associated PI 3-kinase activity in muscle from control or traumatized rats. Basal PI 3-kinase activity was similar among all groups. Insulin-stimulated IRS-1-associated PI 3-kinase activity (Fig. 3) was significantly greater in traumatized vs. fed control rats (417 ± 41 vs. 716 ± 50%, respectively; P < 0.05). PI 3-kinase activity was also greater in traumatized rats compared with fasted control rats (417 ± 41 vs. 558 ± 44%); however, with Bonferroni correction, the latter difference did not reach statistical significance. A similar trend was observed in anti-phosphotyrosine immunoprecipitates; insulin-stimulated phosphotyrosine-associated PI 3-kinase activity tended to be increased in skeletal muscle after surgical trauma (244 ± 46 vs. 335 ± 63% for fed control vs. traumatized rats, respectively; not significant).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Basal and insulin-stimulated IRS-1-associated PI 3-kinase activity in fed, fasted, and traumatized rats (n = 6 in all groups). Hindlimb muscle biopsies were homogenized, and equal amounts of solubilized protein were immunoprecipitated with anti-IRS-1. IRS-1-associated PI 3-kinase activity was assessed as described in METHODS. PI 3-kinase activity was calculated from quantitation of phosphorimage of [32P]PI 3-kinase products. Results are expressed as the mean ± SE percent increases over fed control rats. * P < 0.05 vs. control fed rats.

Akt phosphorylation. The serine/threonine kinase Akt (protein kinase B/Rac), a downstream target of PI 3-kinase, has been implicated to play a role in growth factor signaling to glucose transport and glycogen synthesis (4, 7, 12, 25-27, 39, 44). Thus we assessed basal and insulin-stimulated Akt phosphorylation in skeletal muscle from control or traumatized rats (Fig. 4). Insulin induced a marked phosphorylation of Akt kinase in skeletal muscle from both control and traumatized rats. Multiples of insulin stimulation could not be calculated because of the complete lack of Akt phosphorylation under basal conditions (Fig. 4). Surgical trauma resulted in a 2.2-fold increase (P < 0.05) in insulin-stimulated Akt phosphorylation (100 ± 9 vs. 221 ± 51% for control vs. traumatized rats, respectively).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Basal and insulin-stimulated protein kinase B (Akt) phosphorylation in skeletal muscle from fed control or fasted traumatized rats was determined in hindlimb skeletal muscle as described in METHODS. Top: representative immunoblot of basal (B) and insulin-stimulated (I) Akt phosphorylation in control or surgically traumatized rats. Bottom: quantification of Akt phosphorylation in control (n = 8) or surgically traumatized (n = 8) rats. Results are expressed as means ± SE. For each experiment, densitometric units of each control insulin-stimulated sample were set to 100%. * P < 0.05 vs. control fed rats.

Glucose transport in isolated soleus muscle. Glucose transport was studied in fasted controls (n = 7) and traumatized (n = 7) rats (Fig. 5). Basal (no insulin) glucose transport was similar between the groups (0.77 ± 0.12 vs. 0.73 ± 0.13 µmol · ml-1 · h-1 for traumatized vs. fasted control rats, respectively). Furthermore, the response of glucose transport to a supraphysiological concentration of insulin was similar between the groups (2.87 ± 0.32 vs. 3.70 ± 0.41 µmol · ml-1 · h-1 for traumatized vs. fasted control rats, respectively). The insulin dose response for 3-O-methylglucose transport was significantly different between fasted control and traumatized rats (2-way ANOVA, P < 0.005). Post hoc analysis revealed that glucose transport activity after submaximal insulin stimulation (100 and 200 µU/ml) was significantly lower (P < 0.05) in traumatized vs. fasted rats.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   3-O-methylglucose transport in soleus muscle from fasted control and traumatized rats was determined as described in METHODS. Basal glucose transport was normalized to 0% and maximal insulin-stimulated rate of glucose transport to 100%. Results are expressed as mean ± SE percentages. * P < 0.05 vs. control fed rats (2-way ANOVA).

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

Here we show that surgical trauma in combination with fasting leads to increased insulin receptor phosphorylation and PI 3-kinase activity and reduced insulin-stimulated glucose transport. Furthermore, surgical trauma results in a moderate increase in the plasma concentrations of glucose and epinephrine, with no change in cortisol levels. The reduced submaximal insulin-stimulated glucose transport in skeletal muscle from the traumatized rats suggests that the small bowel resection employed in the present study was sufficient to induce altered glucose homeostasis, a hallmark characteristic of surgical stress. Our finding of reduced insulin-stimulated glucose transport in skeletal muscle is consistent with previous reports in which marked peripheral insulin resistance has been observed after different forms of catabolic stress, including burns, sepsis, accidental trauma, and surgery in humans (3, 17, 23, 30, 41, 47, 48).

Fasting increases insulin signaling in skeletal muscle at the level of the insulin receptor, IRS-1 (37) and PI 3-kinase (19). The increase in insulin receptor phosphorylation after surgical stress in combination with fasting was accompanied with an increase in PI 3-kinase activity and an increased association of p85 to phosphotyrosines. Despite these changes, insulin-stimulated glucose transport was reduced. Such a dissociation between intermediate and final components of insulin signaling has been observed previously. With streptozotocin-induced diabetes, tyrosine phosphorylation of IRS-1 and IRS-1-associated PI 3-kinase activity is markedly increased in skeletal muscle (11) despite severe insulin resistance (45). Thus trauma-induced insulin resistance in skeletal muscle is neither at the level of the insulin receptor nor at PI 3-kinase but may lie downstream from PI 3-kinase. Recently, the serine/threonine kinase Akt (protein kinase B/Rac) has been suggested to play a role in the signaling pathway to glucose transport (27, 39, 44). We have recently provided evidence that reduced insulin-stimulated Akt activity is associated with reduced glucose transport in muscle from diabetic Goto-Kakizaki rats (28). Interestingly, restoration of glycemia completely normalized insulin action on Akt kinase (28). Consequently, we hypothesized that reduced Akt kinase activity may lead to decreased glucose transport in muscle after surgical trauma. Our finding that surgical stress potentiates the effect of insulin on PI 3-kinase and Akt kinase in skeletal muscle does not support the hypothesis that early or intermediate signaling defects contribute to reduced glucose transport after surgical trauma. Alternatively, the exocytotic machinery for GLUT-4 translocation may be altered by surgical stress such that GLUT-4 vesicles fail to fuse or dock to the plasma membrane, and thus glucose entry into the cell may be impaired. Furthermore, hyperphosphorylation of early components of the insulin signal transduction pathway may lead to negative feedback that inhibits downstream signaling to glucose transport (11).

In the present study, insertion of a venous catheter in fed (i.e., a minor trauma) but not in fasted rats resulted in a marked increase in blood glucose. When fasted rats were subjected to a more severe trauma (small bowel resection), blood glucose was significantly elevated. Thus the degree of posttraumatic hyperglycemia appears to be dependent on both the magnitude of trauma and on substrate availability. This finding is consistent with previous findings observed in an animal model of trauma and starvation (31).

Increased levels of NEFAs may reduce insulin action in skeletal muscle (33). However, in the present study, NEFA levels were lower in traumatized rats compared with fasted controls. Our finding is consistent with previous observations in hyperglycemic postoperative patients (24) and with reports of unchanged NEFA levels in septic patients (47). Furthermore, we found no significant differences in plasma lactate concentrations. Severe trauma may alter the circulatory levels of insulin and insulin-antagonistic hormones such as epinephrine and cortisol, which can affect glucose metabolism (29). However, plasma insulin concentrations were similar between the fasted and traumatized rats. Thus the defect in glucose transport was not due to reduced insulin levels. After intestinal resection, plasma concentrations of epinephrine were moderately increased, whereas cortisol levels were not altered compared with time-matched controls. The endocrine response found in the present study is similar to that observed in postoperative patients, in which epinephrine and cortisol levels are unaltered or moderately increased (17, 32, 41). Thus increased levels of these hormones may be of minor importance for the development of insulin resistance associated with sepsis or moderate surgical stress in humans (32, 47).

In conclusion, insulin resistance in skeletal muscle after surgical trauma is associated with reduced glucose transport but not with impaired insulin signaling to PI 3-kinase. The surgical trauma model presented in this report will be a useful tool to further elucidate the molecular mechanism(s) underlying the development of insulin resistance after surgical trauma.

    ACKNOWLEDGEMENTS

This study was supported by grants from the Swedish Medical Research Council (9517, 10402, 11823, 12211), the Swedish Cancer Society (2870-B96-06XCC), the Novo-Nordisk Foundation, and the Swedish Diabetes Association. J. R. Zierath was the recipient of a Junior Individual Grant from the Foundation for Strategic Research.

    FOOTNOTES

Address for reprint requests: J. Permert, Dept. of Surgery, Huddinge Hospital, 141 86 Huddinge, Sweden.

Received 29 October 1997; accepted in final form 10 April 1998.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Anai, M., M. Funaki, T. Ogihara, J. Terasaki, K. Inukai, H. Katagira, Y. Fukushima, Y. Yazaki, M. Kikuchi, Y. Oka, and T. Asano. Altered expression levels and impaired steps in the pathway to phosphatidylinosital 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47: 13-23, 1998[Abstract].

2.   Björnholm, M., Y. Kawano, M. Lehtihet, and J. R. Zierath. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527, 1997[Abstract].

3.   Black, P. R., D. C. Brooks, P. Q. Bessey, R. R. Wolfe, and D. W. Wilmore. Mechanisms of insulin resistance following injury. Ann. Surg. 196: 420-435, 1982[Medline].

4.   Boudewijn, M. T., and P. J. Coffer. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602, 1995[Medline].

5.   Brandi, L. S., M. Frediani, M. Oleggini, F. Mosca, M. Cerri, C. Boni, N. Pecori, G. Buzzigoli, and E. Ferrannini. Insulin resistance after surgery: normalization by insulin treatment. Clin. Sci. (Colch.) 79: 443-450, 1990[Medline].

6.   Dahn, M. S., R. A. Mitchell, P. Lange, S. Smith, and L. A. Jacobs. Hepatic response to injury and sepsis. Surgery 117: 520-530, 1995[Medline].

7.   Didichenko, S. A., B. Tilton, B. A. Hemmings, K. Ballmer-Hofer, and M. Thelen. Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase. Curr. Biol. 6: 1271-1278, 1996[Medline].

8.   Elmendorf, J. S., A. Damrau-Abney, T. R. Smith, T. S. David, and J. Turinsky. Insulin-stimulated phosphatidylinositol 3-kinase activity and 2-deoxy-D-glucose uptake in rat skeletal muscles. Biochem. Biophys. Res. Commun. 208: 1147-1153, 1995[Medline].

9.   Eskola, J. U., V. Näntö, L. Meurling, and T. N. E. Lövgren. Direct solid-phase time resolved immunofluorometric assay of cortisol in serum. Clin. Chem. 31: 1731-1734, 1985[Abstract/Free Full Text].

10.   Fink, R. I., P. Wallace, G. Brechtel, and J. M. Olefsky. Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 41: 867-902, 1992.

11.   Folli, F., M. J. A. Saad, J. M. Backer, and C. R Kahn. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J. Clin. Invest. 92: 1787-1794, 1993[Medline].

12.   Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995[Medline].

13.   Frayn, K. N. Hormonal control of metabolism in trauma and sepsis. Clin. Endocrinol. (Oxf.) 24: 577-599, 1986[Medline].

14.   Goodyear, L., F. Giorgino, L. A. Sherman, J. Carey, R. J. Smith, and G. L. Dohm. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95: 2195-2204, 1995[Medline].

15.   Gumbiner, B., J. F. Mucha, J. E. Lindstrom, I. Rekhi, and J. N. Livingston. Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylation. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E424-E429, 1996[Abstract/Free Full Text].

16.   Hallman, H., L.-O. Farnebo, B. Hamberger, and G. Jonsson. A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci. 23: 1049-1052, 1978[Medline].

17.   Henderson, A. A., K. N. Frayn, S. B. Galasco, and R. A. Little. Dose response relationships for the effects of insulin on glucose and fat metabolism in injured patients and control subjects. Clin. Sci. (Colch.) 80: 25-32, 1990.

18.   Heydrick, S. J., N. Gautier, C. Olichon-Berthe, E. Van Obberghen, and Y. Le Marchand-Brustel. Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E604-E612, 1995[Abstract/Free Full Text].

19.   Heydrick, S. J., D. Jullien, N. Gautier, J. F. Tanti, S. Giorgetti, E. Van Oberberghen, and Y. Le Marchand-Brustel. Defect in skeletal muscle phosphatidyl-3-kinase in obese insulin-resistant mice. J. Clin. Invest. 91: 1358-1366, 1993[Medline].

20.   Howard, J. M. Studies of the absorption and metabolism of glucose following injury. Ann. Surg. 141: 321-326, 1955.

21.   Inukai, K., M. Anai, E. Van Breda, T. Hosaka, H. Katagiri, M. Funaki, Y. Fukushima, T. Ogihara, Y. Yazaki, M. Kikuchi, Y. Oka, and T. Asano. A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85alpha gene. J. Biol. Chem. 271: 5317-5320, 1996[Abstract/Free Full Text].

22.   Inukai, K., M. Funaki, T. Ogihara, H. Katagiri, A. Kanda, M. Anai, Y. Fukushima, T. Hosaka, M. Suzuki, B.-C. Shin, K. Takata, Y. Yazaki, M. Kikuchi, Y. Oka, and T. Asano. p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-kinase), p50alpha , p55alpha , and p85alpha , with different response to insulin. J. Biol. Chem. 272: 7873-7882, 1997[Abstract/Free Full Text].

23.   Jahoor, F., W. R. E. Shangraw, H. Miyoshi, H. Walfish, D. N. Herndon, and R. R. Wolfe. Role of insulin and glucose oxidation mediating the protein catabolism of burn and sepsis. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E323-E331, 1989[Abstract/Free Full Text].

24.   Kaukinen, S., J. Salmi, A. Marttinen, and T. Koivula. Postoperative hyperglycemia---are the patients diabetic? Exp. Clin. Endocrinol. 100: 85-89, 1992[Medline].

25.   Klippel, A., C. Reinhard, W. M. Kavanaugh, G. Apell, M. A. Escobedo, and L. T. Williams. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transduction kinase pathways. Mol. Cell. Biol. 16: 4117-4127, 1996[Abstract].

26.   Kohn, A. D., K. S. Kovacina, and R. A. Roth. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 14: 4288-4295, 1995[Abstract].

27.   Kohn, A. D., S. A. Summers, M. J. Birnbaum, and R. A. Roth. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271: 31372-31378, 1996[Abstract/Free Full Text].

28.   Krook, A., Y. Kawano, X. M. Song, S. Efendic, R. A. Roth, H. Wallberg-Henriksson, and J. R. Zierath. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 46: 2110-2114, 1997[Abstract].

29.   Lager, I. The insulin-antagonistic effect of the counterregulatory hormones. J. Intern. Med. 229: 41-47, 1991[Medline].

30.   Lang, C. H., C. Dobrescu, and K. Mézáros. Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism 39: 1096-1107, 1990[Medline].

31.   Ljungqvist, O., S. Efendic, P. Eneroth, B. Hamberger, G. Nylander, and J. Ware. Nutritional status and endocrine response to hemorrhage. Can. J. Physiol. Pharmacol. 64: 1185-1188, 1985.

32.   Ljungqvist, O., A. Thorell, M. Gutniak, T. Häggmark, and S. Efendic. Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance. J. Am. Coll. Surg. 178: 329-336, 1994[Medline].

33.   McKane, W. R., A. B. Stevens, R. Woods, W. J. Andrews, R. W. Henry, and P. M. Bell. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metab. Clin. Exp. 39: 1240-1245, 1990.[Medline]

34.   Nordenström, J., T. Sonnenfeld, and P. Arner. Characterization of insulin resistance after surgery. Surgery 105: 28-35, 1989[Medline].

35.   Nygren, J., A. Thorell, S. Efendic, K. Sree, and O. Ljungqvist. Site of insulin resistance after surgery; the contribution of hypocaloric nutrition and bed rest. Clin. Sci. (Colch.) 93: 137-143, 1997[Medline].

36.   Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269: 3568-3573, 1994[Abstract/Free Full Text].

37.   Saad, M. J. A., E. Araki, M. Miralpeix, P. L. Rothenberg, M. F. White, and C. R. Kahn. Regulation of insulin receptor substrate-1 of animal models of insulin resistance. J. Clin. Invest. 90: 1839-1849, 1992[Medline].

38.   Shepherd, P. R., B. Navé, J. Rincon, L. A. Nolte, A. P. Bevan, K. Siddle, J. R. Zierath, and H. Wallberg-Henriksson. Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle. J. Biol. Chem. 272: 19000-19007, 1997[Abstract/Free Full Text].

39.   Tanti, J.-F., S. Grillo, T. Grémeaux, P. J. Coffer, E. Van Obberghen, and Y. Le Marchand-Brustel. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138: 2005-2010, 1997[Abstract/Free Full Text].

40.   Thorell, A., S. Efendic, M. Gutniak, T. Häggmark, and O. Ljungqvist. Development of postoperative insulin resistance is associated with the magnitude of operation. Eur. J. Surg. 159: 593-599, 1993[Medline].

41.   Thorell, A., S. Efendic, M. Gutniak, T. Häggmark, and O. Ljungqvist. Insulin resistance after abdominal surgery. Br. J. Surg. 81: 59-63, 1994[Medline].

42.   Thorell, A., J. Nygren, P. Essén, M. Gutniak, A. Loftenius, B. Andersson, and O. Ljungqvist. The metabolic response to cholecystectomy: insulin resistance after open cholecystectomy compared to laporascopic operation. Eur. J. Surg. 162: 87-191, 1996[Medline].

43.   Uchida, I., T. Asoh, C. Shirasaka, and H. Tsuji. Effect of epidural analgesia on postoperative insulin resistance as evaluated by clamp technique. Br. J. Surg. 75: 557-562, 1988[Medline].

44.   Ueki, K., R. Yamamoto-Honda, Y. Kaburagi, T. Yamauchi, K. Tobe, B. M. T. Burgering, P. J. Coffer, I. Komuro, Y. Akanuma, Y. Yazaki, and T. Kadowaki. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273: 5315-5322, 1998[Abstract/Free Full Text].

45.   Wallberg-Henriksson, H., N. Zetan, and J. Henriksson. Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. J. Biol. Chem. 262: 7665-7671, 1987[Abstract/Free Full Text].

46.   White, M. F., and C. R. Kahn. The insulin signaling system. J. Biol. Chem. 269: 1-4, 1994[Free Full Text].

47.   White, R. H., K. N. Frayn, R. A. Little, C. J. Threfall, H. B. Stoner, and M. H. Irving. Hormonal and metabolic responses to glucose infusion in sepsis studied by the hyperglycemic glucose clamp technique. J. Parenter. Enteral Nutr. 11: 345-353, 1987[Abstract].

48.   Wolfe, R. R., M. J. Durcott, J. R. Alsop, and J. F. Burk. Glucose metabolism in severely burned patients. Metabolism 218: 1031-1039, 1979.

49.   Zierath, J. R., K. L. Houseknecht, L. Gnudi, and B. B. Kahn. High fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin signaling defect. Diabetes 46: 215-223, 1997[Abstract].


Am J Physiol Endocrinol Metab 275(2):E351-E358
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society